|
HINFP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.094400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.997560E-01 |
| Normal-vs-Stage2 |
4.498400E-02 |
| Normal-vs-Stage3 |
1.207720E-02 |
| Normal-vs-Stage4 |
3.768100E-02 |
| Stage1-vs-Stage2 |
1.550430E-01 |
| Stage1-vs-Stage3 |
5.824000E-02 |
| Stage1-vs-Stage4 |
2.131800E-01 |
| Stage2-vs-Stage3 |
9.540200E-01 |
| Stage2-vs-Stage4 |
8.457200E-01 |
| Stage3-vs-Stage4 |
8.531400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.835800E-02 |
| Normal-vs-AfricanAmerican |
7.244000E-01 |
| Normal-vs-Asian |
6.853000E-01 |
| Caucasian-vs-AfricanAmerican |
3.461400E-01 |
| Caucasian-vs-Asian |
1.822620E-01 |
| AfricanAmerican-vs-Asian |
9.682000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.594750E-01 |
| Normal-vs-Female |
3.875600E-02 |
| Male-vs-Female |
5.345000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.308000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.010400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.047670E-02 |
| Normal-vs-Age(81-100Yrs) |
6.937900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.828200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.604400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.417790E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.992600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.174460E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.388000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.475630E-03 |
| Classical-VS-Follicular |
5.852400E-02 |
| Classical-VS-Other |
6.339000E-01 |
| Classical-VS-Normal |
2.217000E-01 |
| Tall-VS-Follicular |
4.647400E-01 |
| Tall-VS-Other |
2.615000E-01 |
| Tall-VS-Normal |
1.142530E-03 |
| Follicular-VS-Other |
3.507400E-01 |
| Follicular-VS-Normal |
1.875550E-02 |
| Other-VS-Normal |
9.790200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.313800E-02 |
| Normal-vs-N1 |
1.165800E-01 |
| N0-vs-N1 |
8.439000E-01 |
|
|
